戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 neurotransmission (dopamine, benzodiazepine, serotonin receptors).
2 tes, and modulates signaling of the 5-HT(2A) serotonin receptor.
3  cell surface through an as yet unidentified serotonin receptor.
4 re transfected with 14 different isoforms of serotonin receptor.
5 in releasing hormone receptor, and the 5HT1a serotonin receptor.
6  BST, and of neuron populations that express serotonin receptors.
7 cular explanation for LSD's actions at human serotonin receptors.
8 functions and behavior by directly targeting serotonin receptors.
9 ly members for its interactions with defined serotonin receptors.
10 hich tryptamine-related agents bind at 5-HT6 serotonin receptors.
11 e polyomavirus and SV40, while JC virus uses serotonin receptors.
12 arinic M1 and M3, neurokinin, opioid KOP and serotonin receptors.
13 circuits are modulated via several different serotonin receptors.
14 of GABA-positive neurons are associated with serotonin receptors.
15  mRNAs, including the mRNAs of glutamate and serotonin receptors.
16  raphe nuclei, and expresses high density of serotonin receptors.
17  purposes, particularly in the modulators of serotonin receptors.
18 As, including the pre-mRNAs of glutamate and serotonin receptors.
19 from its mixed agonist/antagonist profile at serotonin receptors.
20 mine receptors, but instead by activation of serotonin receptors.
21 ntly enhances currents mediated by GABAA and serotonin receptors.
22 ogy of its recognition of the 5-HT1 class of serotonin receptors.
23 nge eating, and the contribution of specific serotonin receptors.
24 er insect amine receptors and the vertebrate serotonin receptors.
25 wo serotonin-related gene polymorphisms, the serotonin receptor 1A (5-HT1A) polymorphism at -1019C>G
26                  Activation or inhibition of serotonin receptor 1A (5-HTR1A) recapitulated or abolish
27 (miR135), and both serotonin transporter and serotonin receptor-1a transcripts.
28 arge family of S100 proteins, interacts with serotonin receptor 1B (5-HTR1B), modulates 5-HT1B recept
29  by serotonin, acting through the Drosophila serotonin receptor 1B (d5-HT1B).
30   Furthermore, pharmacological inhibition of serotonin receptor 1B with SB224289, and of receptor 2A
31 d agonists for members of the 5-HT2 class of serotonin receptors, 2,5-dimethoxy-4-iodoamphetamine (DO
32                             We show that the serotonin receptor 2A (5-HT(2A)), a prototypical GPCR in
33                          Upregulation of the serotonin receptor 2A (5-HT(2A)R) in dorsal horn neurons
34 hoxy-4-iodoamphetamine (DOI), an agonist for serotonin receptor 2A (5-HT2AR).
35 and identified tryptophan hydroxylase (Trh), serotonin receptor 2a (5HT2a), and the solute carrier 7-
36 xplored the roles of two of these receptors, serotonin receptor 2A (5HTR2A) and the D4 dopamine recep
37 ound that adrenoceptor alpha 2C (Adra2c) and serotonin receptor 2a (Htr2a) were the most highly expre
38 ms in the monoamine oxidase A (MAOA-LPR) and serotonin receptor 2A genes (rs6314) moderated the effec
39              Editing of the pre-mRNA for the serotonin receptor 2C (5-HT2CR) by site-specific adenosi
40 (SCI) leads to a decrease in mRNA editing of serotonin receptor 2C (5-HT2CR) contributing to post-SCI
41                                          The serotonin receptor 2C plays a central role in mood and a
42 I-52 changes the alternative splicing of the serotonin receptor 2C pre-mRNA, which is different from
43 tophan hydroxylase 1 (Tph1, rs262731280) and serotonin receptor 3A (Htr3a, rs50670893) were associate
44   Noncoding variants in 5-hydroxytryptamine (serotonin) receptor 4 (HTR4) are associated with pulmona
45 affinity agonist of the 5-hydroxytryptamine (serotonin) receptor 4 that enhances motility in the gast
46 tions in editing and alternative splicing of serotonin receptor 5-HT(2C) transcripts.
47  we demonstrated that LK neurons express the serotonin receptor 5-HT1B .
48 shown to be independent of their function as serotonin receptor 5-HT1B/1D agonist or cytostatic drug,
49 s for each of these receptors and found that serotonin receptor 5-HT2A is the sole molecular target f
50 l structure of LSD in complex with the human serotonin receptor 5-HT2B.
51 n is a peripherally active antagonist of the serotonin receptor 5-HT3, and is marketed for prevention
52  monoamine oxidase A (serotonin catabolism), serotonin receptor 5-HT4, or mouse serotonin transporter
53 lactoseries tetrasaccharide c (LSTc) and the serotonin receptor 5-hydroxytryptamine (5-HT) receptor 5
54          Preclinical evidence implicates the serotonin receptor 5-hydroxytryptamine 1B (5-HT1B) in th
55          Expression of the G alpha(q)-linked serotonin receptor 5-hydroxytryptamine receptor-2b (Htr2
56                 Constitutive activity of the serotonin receptors 5-HT2B/C is required for the develop
57          Several studies have shown that the serotonin receptors 5-HTR1b and 5-HTR4 play key roles in
58 reversal of hypothalamic NPY, alpha-MSH, and serotonin receptor (5-HT(1B)-receptor) enhancing FI.
59 n reuptake transporter (SERT) and the type 7 serotonin receptor (5-HT(7)) were expressed in human and
60         [11C]CUMI-101 is the first selective serotonin receptor (5-HT1AR) partial agonist radiotracer
61 li (noc), and confirmed that Ftz regulates a serotonin receptor (5-HT2).
62                    Antagonists of the type 3 serotonin receptor (5-HT3) have shown promising results
63 ypes: alpha7-nAChR, alpha4beta2-nAChR, and a serotonin receptor (5-HT3AR), along with a fluorescent r
64 y with CA1 pyramidal cells via activation of serotonin receptors (5-HT(1B)Rs), without affecting near
65                                 5-HT(2)-type serotonin receptors (5-HT(2)Rs) are widely expressed thr
66              A new homology model of type-3A serotonin receptors (5-HT(3A)Rs) was built on the basis
67 se to 5-hydroxytryptamine (5-HT), the type 1 serotonin receptors (5-HT1Rs) preferentially couple to t
68                                Expression of serotonin receptors (5-HTR), transporter (5-HTT), and tr
69 emical localization of the crustacean type 1 serotonin receptor, 5-HT1crust, throughout the crayfish
70                               The ionotropic serotonin receptor, 5-HT3 , is expressed by many develop
71 tors, we have cloned and fully sequenced two serotonin receptors, 5-HT(1Mac) and 5-HT(2Mac), from the
72 cocorticoid receptor (GR) and an increase in serotonin receptor 5HT-1a, consistent with the decreased
73 tropic glutamate receptors, GluR2-6, and the serotonin receptor, 5HT2C.
74                                          The serotonin receptor 5HT2CR pre-mRNA is subject to adenosi
75 ncluding somatostatin receptor 3 (Sstr3) and serotonin receptor 6 (Htr6), localize to cilia.
76 ansport of two different cargoes (membranous serotonin receptor 6-green fluorescent protein [HTR6-GFP
77 mine (5-HT)), and we found that knockdown of serotonin receptor-6 (5-Htr6) expression or pharmacologi
78  E2 series prostaglandins and DHA influences serotonin receptor action by increasing cell membrane fl
79 tion, the intracellular signal mediating the serotonin receptor action in cholangiocytes was characte
80  nerve activity has been reported to require serotonin receptor activation and protein syntheses.
81 We conclude that phrenic LTF requires spinal serotonin receptor activation and protein synthesis.
82 hat LTF of phrenic amplitude requires spinal serotonin receptor activation and spinal protein synthes
83                                              Serotonin receptor activation by serotonin showed a simi
84 we show that presynaptic cAMP generation via serotonin receptor activation directly modulated hyperpo
85                         pLTF requires spinal serotonin receptor activation, new BDNF synthesis and Tr
86                               In the case of serotonin, receptor activation rates varied with agonist
87 ding and behavioral tests to determine their serotonin receptor activities.
88 syndrome patients with a clinically-approved serotonin receptor agonist (lorcaserin, Belviq(R)) and o
89 opropan-1-ol (6), an analogue of the 5-HT(2) serotonin receptor agonist 1-(4-bromo-2,5-dimethoxypheny
90 es a paradoxical response to the nonspecific serotonin receptor agonist m-chlorophenylpiperazine (mCP
91                              Psilocybin is a serotonin receptor agonist that occurs naturally in some
92 ase inhibitor) and pergolide (a dopamine and serotonin receptor agonist) robustly reduced alcohol int
93 ith 5-nonyloxytryptamine (5-NT), a prototype serotonin receptor agonist, diminished reovirus cytotoxi
94 c acid diethylamide (LSD) is a non-selective serotonin-receptor agonist that was first synthesized in
95 ment for menstrual migraine is inconsistent, serotonin receptor agonists (triptans) provide acute rel
96                          Observed effects of serotonin receptor agonists and antagonists in abdomen p
97 uts onto IO cells are strongly suppressed by serotonin receptor agonists as well as release of endoge
98                             Because 5-HT(2A) serotonin receptor agonists might also produce undesirab
99 rain, attempts were made to identify 5-HT(2) serotonin receptor agonists with reduced propensity to p
100 esic agents (prostaglandin E2 and purine and serotonin receptor agonists) resulted in reduction in hy
101  of osteoblast numbers because inhibition of serotonin receptors alone in leukemic blasts did not aff
102         We immunized mice with the rat 5HT2c serotonin receptor and derived clonal hybridoma cells, w
103 vatives as selective inhibitors of the 5-HT6 serotonin receptor and the TRPV1 ion channel.
104                                 Dopamine and serotonin receptor and transporter genes have been an ea
105          These include drugs that act on the serotonin receptor and transporter system: antidepressan
106 acts with 5-hydroxytryptamine(2A) (5-HT(2A)) serotonin receptors and attenuates receptor signaling vi
107       We demonstrate that clemizole binds to serotonin receptors and its antiepileptic activity can b
108 imaging-based human brain atlas of important serotonin receptors and the transporter.
109 st notably, we found changes in dopamine and serotonin receptors and transporters (Dat1, Drd4, 5Htt,
110 ndent substituents, certain receptors (e.g., serotonin receptors) and monoamine transporters (i.e., s
111   The prototypical hallucinogen LSD acts via serotonin receptors, and here we describe the crystal st
112 00A10 (p11) was identified as a regulator of serotonin receptors, and it has been implicated in the e
113 nosine residues in a subset of glutamate and serotonin receptors, and this editing results in protein
114                    The distribution of LSTc, serotonin receptors, and virus binding sites overlapped
115 s are compared with those obtained following serotonin receptor antagonism or episodic carotid sinus
116 1 receptor antagonists (NK1-RAs) and the new serotonin receptor antagonist (5HT3-RA) palonosetron.
117                             A broad-spectrum serotonin receptor antagonist (methysergide) or protein
118 longer recommends the combination of a 5-HT3 serotonin receptor antagonist and dexamethasone for the
119 SSRI fluoxetine and fluvoxamine and the 5-HT serotonin receptor antagonist cyproheptadine were conduc
120 nsulin receptor, or pharmacologically by the serotonin receptor antagonist cyproheptadine.
121 icated healthy comparison women received the serotonin receptor antagonist metergoline as part of a d
122 ytryptamine affects phosphate excretion, the serotonin receptor antagonist methiothepin (20 microgram
123          The bilateral administration of the serotonin receptor antagonist methysergide (2.5 microg,
124 or depotentiation, by DSI was blocked by the serotonin receptor antagonist methysergide and mimicked
125                             Furthermore, the serotonin receptor antagonist methysergide blocked this
126 ere occluded by serotonin and blocked by the serotonin receptor antagonist methysergide, suggesting t
127                       Spinal methysergide, a serotonin receptor antagonist, blocked apnoea-induced LT
128 ination of a 5-hydroxytryptamine-3 (5-HT(3)) serotonin receptor antagonist, dexamethasone, and aprepi
129 ), dexamethasone, and dolasetron mesylate, a serotonin receptor antagonist.
130      Hairless mice were injected with PAF or serotonin receptor antagonists and then exposed to solar
131                                 Type 2 and 3 serotonin receptor antagonists attenuated serotonin's po
132                         Also, the PAF and/or serotonin receptor antagonists blocked skin cancer progr
133 eatment of mammary epithelial membranes with serotonin receptor antagonists increased their transepit
134                                              Serotonin receptor antagonists may thus be useful in the
135                        Pretreatment with the serotonin receptor antagonists methysergide (4 mg/kg, i.
136                                     Although serotonin receptor antagonists remain key in the multimo
137 ed as an affinity matrix in the screening of serotonin receptor antagonists with known affinities for
138                                  The PAF and serotonin receptor antagonists worked in a synergistic f
139 atients intolerant of or refractory to 5-HT3 serotonin receptor antagonists, neurokinin-1 receptor an
140 pling of the second messenger cascade to the serotonin receptor appearing quite late.
141 gy" and discuss how drugs targeting specific serotonin receptors are beginning to help treat a wide r
142                      The effects of blocking serotonin receptors are complex and cannot be interpreta
143  nervous system, and virtually all of the 15 serotonin receptors are expressed outside as well as wit
144            5-Hydroxytryptamine 2A (5-HT(2A)) serotonin receptors are important for a variety of funct
145                  In addition to LSTc, type 2 serotonin receptors are required for facilitating virus
146                                     5-HT(2A) serotonin receptors are unusual among G-protein coupled
147 ychological processes, and drugs that target serotonin receptors are used widely in psychiatry and ne
148  are mediated through specific histamine and serotonin receptors, are independent of VEGF-A, and are
149      Antipsychotic drugs target dopamine and serotonin receptors as well as Kv11.1 potassium channels
150 ion of the 5-HT3 receptor, all of the cloned serotonin receptors belong to the G protein-coupled rece
151 rotonin content, serotonin uptake sites, and serotonin receptor binding measured in animal studies ar
152                 Because PCA 4248 also blocks serotonin receptor binding, we measured the effect that
153 riction was largely antagonized by selective serotonin receptor blockade, with little further antagon
154 the functional activity of not only 5-HT(2A) serotonin receptors but also selected Galpha(q)-coupled
155 s effect through the specific binding to the serotonin receptor, but recent research has suggested th
156  sulfonamides, sulfones) bind at human 5-HT6 serotonin receptors, but it has been difficult relating
157 regulate the expression of Htr2c, one of the serotonin receptors, by binding to its promoter, and the
158 -length N-acetylated peptides from the 5HT2c serotonin receptor C-terminal sequence, as well as for o
159                                              Serotonin receptors can now be included among the molecu
160 in systems and may play an etiologic role in serotonin receptor changes observed in patients with maj
161 ge of recent findings demonstrating that the serotonin receptor chaperone, p11, is an important molec
162                                    Canonical serotonin receptor compounds have given way to a myriad
163        Competition binding assays at several serotonin receptors confirmed that an N-arylmethyl subst
164 hment receptor for JCPyV and that the type 2 serotonin receptors contribute to JCPyV infection by fac
165         However, variation in genes encoding serotonin receptors could also explain antidepressant si
166 es, such as D2 dopamine receptors and 5-HT2A serotonin receptors, could evolve a mechanism that discr
167                                     Although serotonin receptor density is greatest in brain regions
168 uate their long-term effects on dopamine and serotonin receptors density in different brain areas.
169 A) receptors in cells stably expressing this serotonin receptor did not alter cGMP levels.
170 n no reports demonstrating the expression of serotonin receptor dimers/oligomers on the plasma membra
171 rotein-coupled acetylcholine, glutamate, and serotonin receptors downregulate GAT1 function.
172     The study provides valuable insight into serotonin receptor (dys)function in a limbic brain area.
173           Two different forms of the 5-HT(3) serotonin receptor, each with a different desensitizatio
174  affects diarrhea and anxiety via effects on serotonin receptors, enhanced intestinal repair, and sod
175                                        Thus, serotonin receptor-evoked facilitatory actions are compl
176 meric GABArho1, alpha7 nicotinic, and 5-HT3A serotonin receptors expressed in Xenopus oocytes.
177 pressing GABAergic interneurons, a subset of serotonin receptor-expressing interneurons.
178 s are needed to determine whether postmortem serotonin receptor findings are also present in vivo and
179 LTF is serotonin dependent, and the relevant serotonin receptors for phrenic LTF are located in the c
180 ults indicate that a genetic perturbation of serotonin receptor function can modulate dentate gyrus p
181 llular expression patterns of the Drosophila serotonin receptor gene family.
182 he regulation of alternative splicing of the serotonin receptor gene in humans and other mammals.
183 dopamine receptor (Gs-coupled) and the 5HT1E serotonin receptor (Gi-coupled) mediated cellular prolif
184 gents, which block postsynaptic dopamine and serotonin receptors, have advantages over traditional an
185 rtex of Phf8 deficient mice and identify the serotonin receptors Htr1a and Htr2a as direct targets of
186                      We demonstrate that the serotonin receptor htr2a is expressed on these commissur
187 ilution phenotype was also observed with the serotonin receptor Htr6, fibrocystin PKHD1, and Arl13b.
188      This survey led to the discovery of the serotonin receptor HTR7 as a key mediator of serotonergi
189 ng, presumably through its action on various serotonin receptors (HTRs).
190 on of a dopamine receptor effectively into a serotonin receptor illustrates the plasticity of GPCR si
191 onclusion, 5-HT7 receptor is a novel type of serotonin receptor implicated in hepatocyte proliferatio
192 tivity suggests that they do not bind to the serotonin receptor in a way such that the tricyclic naph
193 plicated the 5-hydroxytryptamine 2B (5-HT2B) serotonin receptor in mediating the heart valve fibropla
194            For activating pumping, the SER-7 serotonin receptor in the MC motor neurons in the feedin
195            The finding that ergotamine binds serotonin receptors in a less conserved extended binding
196              Antipsychotic compounds bind at serotonin receptors in human prefrontal cortex.
197               To further define the roles of serotonin receptors in infection, HEK293A cells, which a
198  These findings suggest an important role of serotonin receptors in mediating the discriminative stim
199  This study aimed to determine levels of two serotonin receptors in subtypes of vascular dementia and
200                        Postmortem studies of serotonin receptors in suicides localize changes to the
201 d to study the relationship between GABA and serotonin receptors in the central nucleus of the rat in
202        We studied the role of adrenergic and serotonin receptors in the generation of superoxide by r
203 roxytryptamine (5-HT) 2A (5-HT2A) and 5-HT2C serotonin receptors in the hypothalamus were altered by
204 e differential roles of distinct families of serotonin receptors in this process and propose that reg
205 rally and directly activates SER-7, a type 7 serotonin receptor, in MC motor neurons in the feeding o
206 found that omega-3 fatty acids could prevent serotonin receptor-induced MAPK activation in hippocampa
207 -dependent pMF, which was enhanced by spinal serotonin receptor inhibition.
208            The association between selective serotonin receptor inhibitors (SSRIs) and risk of upper
209                                 The 5-HT(2A) serotonin receptor is the most abundant serotonin recept
210                       Glycosylation of other serotonin receptors is essential for expression, ligand
211 ferences in biological activity suggest that serotonin receptor isoforms are very sensitive to subtle
212 onist propranolol (1) binds at rodent 5-HT1B serotonin receptors, it displays low affinity (Ki > 10,0
213           Our findings identify cis-UCA as a serotonin receptor ligand and indicate that the immunosu
214 T1AR, and 5-HT6R as potent dual 5-HT7/5-HT2A serotonin receptors ligands.
215 en little examination of the influences that serotonin receptors may play in modulating feeding withi
216  to play an important role in cognition, and serotonin receptors may provide a novel target for futur
217  gamma-aminobutyric acid, acetylcholine, and serotonin receptors, may also be erroneously modeled, an
218 c manipulation and western blot detection of serotonin receptors, measurements of serotonin, high-spe
219 es in behavior, although it is unclear which serotonin receptors mediate this effect.
220 rebrospinal fluid of sleep-deprived cats, on serotonin receptor-mediated responses were investigated
221 TGF-beta1 expression and activity because of serotonin receptor-mediated signal transduction with act
222  GPCRs, including histamine receptors, 5-HT (serotonin) receptors, muscarinic acetylcholine receptor,
223 ght to elicit their psychotropic actions via serotonin receptors of the 5-hydroxytryptamine 2A subtyp
224  previously that pharmacologic activation of serotonin receptors on motor neurons increases motor neu
225                                              Serotonin receptors on phrenic motoneuron dendrites may
226 lected genetic polymorphisms of dopamine and serotonin receptors or transporters were linked with agg
227 stablish their relationships to other insect serotonin receptors, other insect amine receptors and th
228                                  The 5-HT(3) serotonin receptor plays an important role in regulating
229 to dissect the specific function of distinct serotonin receptor populations across the life course, w
230 ography to determine whether aging decreases serotonin receptor populations in male Syrian hamsters.
231 flexibility, the contributions of particular serotonin receptors remain unclear.
232                                     5-HT(2A) serotonin receptors represent the principal molecular ta
233                       Activation of 5-HT(2A) serotonin receptors represents a novel approach to lower
234 l sites where 5-hydroxytryptamine2A (5-HT2A) serotonin receptors respond to the action of hallucinoge
235 vo many of the key molecular sites-including serotonin receptors, reuptake transporters, and enzymes-
236 gand-independent, constitutively active 5HT4 serotonin receptor (Rs1) to address how the massive incr
237 olecular chaperones through the metabotropic serotonin receptor SER-1.
238  ion channel MOD-1 and the G-protein-coupled serotonin receptor SER-4.
239 biosynthetic enzyme TPH-1 in neurons and the serotonin receptor SER-7 in the intestine.
240 r and cellular target of citalopram, and the serotonin receptors SER-1 and SER-4 were strong genetic
241  of these aminergic receptors, including two serotonin receptors (ser-1 and ser-4), one tyramine rece
242 We found that non-endogenous agonists of the serotonin receptor share a particular IET spectral aspec
243                      These data suggest that serotonin receptor signaling influences cellular activit
244 he antiviral properties of 5-NT suggest that serotonin receptor signaling is an important regulator o
245 ions of serotonin have been assigned through serotonin-receptor-specific drugs and mutants; however,
246        This cellular segregation indicates a serotonin-receptor-specific segmentation of the GABAergi
247                                  Blockers of serotonin receptors, specifically the 5-HT(2A) receptor,
248 nscriptional repression includes the 5-Htr2a serotonin receptor, strongly associated with anxiety- an
249                                          The serotonin receptor subtype 5-HT(1A) was one of the first
250 y was used to advance the novel concept that serotonin receptor subtype 5-HT2C contributes critically
251 nputs from the basolateral nucleus (BLA) and serotonin receptor subtype 5-HT2CR in the BLA, but not C
252 t serotonin 2A is the predominant excitatory serotonin receptor subtype at hypoglossal motor neurons.
253 ferentially high affinities for a particular serotonin receptor subtype capable of stimulating mitoge
254 (2A) serotonin receptor is the most abundant serotonin receptor subtype in the cortex and is predomin
255 ty, little is known of the influence of this serotonin receptor subtype on prefrontal function.
256 may involve an upregulation of a non-5-HT(2) serotonin receptor subtype or subtypes.
257  the distribution and function of the 5-HT5A serotonin receptor subtype, we generated knockout mice l
258 ength, accomplished by activating a specific serotonin receptor subtype.
259  but with reduced functional potency at this serotonin receptor subtype.
260  which activates cardiac afferents through a serotonin receptor (subtype 3,5-HT3 receptor) mechanism,
261 tered expression of each of three Drosophila serotonin receptor subtypes (d5-HT1A, d5-HT1B, and d5-HT
262                                          The serotonin receptor subtypes 2 comprise 5-HT2A, 5-HT2B, a
263     The effects of antagonists selective for serotonin receptor subtypes 2A, 2C, or 7 on intrinsic hy
264 alogs may permit the selective modulation of serotonin receptor subtypes and even have opposing effec
265 ols) were screened for activity at 11 cloned serotonin receptor subtypes by use of ligand-binding met
266                         The presence of many serotonin receptor subtypes enables selective drugs to b
267               The functional significance of serotonin receptor subtypes implicated in excitation of
268                     This characterization of serotonin receptor subtypes in the hypoglossal nucleus p
269  Initial experiments designed to clone novel serotonin receptor subtypes in the substantia nigra have
270 ceptor subtype 5-HT(1A) was one of the first serotonin receptor subtypes pharmacologically characteri
271 Sstr3 and Htr6 are the only somatostatin and serotonin receptor subtypes that localize to cilia, we h
272 ly characterize in SAVIC cultures the native serotonin receptor subtypes using specific agonists and
273  to suggest that the activation of different serotonin receptor subtypes within the feeding circuitry
274            We compared the expression of two serotonin receptor subtypes, the G-protein-coupled 5-hyd
275 gnition and activation of these compounds at serotonin receptor subtypes.
276 ffects of cocaine in mice lacking one of the serotonin-receptor subtypes, the 5-HT1B receptor.
277             On the other hand, activation of serotonin receptors supplements signaling through the P2
278             None of the other 11 isoforms of serotonin receptor supported JCPyV infection.
279 e behavioral hypersensitivity with selective serotonin receptor targeting.
280 ine2A (5-HT2A) receptor is a G(q/11)-coupled serotonin receptor that activates phospholipase C and in
281 amine receptor, and LGC-40 is a low-affinity serotonin receptor that is also gated by choline and ace
282  Salvinorin A had no actions at the 5-HT(2A) serotonin receptor, the principal molecular target respo
283 ptor (5-HT(6)R) represent the most promising serotonin receptor therapeutic targets.
284 suggest that EGL-30 may directly couple to a serotonin receptor to mediate egg laying.
285 ty of the lamprey 5-hydroxytryptamine1b-type serotonin receptor to reduce excitatory postsynaptic cur
286  additional proteins that appear to act with serotonin receptors to mediate serotonin response.
287 er in the viral vector could be regulated by serotonin receptor type 1 (5-HT(1)) agonists.
288                   Oral administration of the serotonin receptor type 1A agonist buspirone prior to le
289 ts also support the development of selective serotonin receptor type 1A agonists for use as antidyski
290 entified as an endogenous binding partner of serotonin receptor type 2c (5HT2c).
291 t controlled by 5-HT(2)Rs must involve other serotonin receptor types and/or secondary signaling even
292  To this end we cloned all four known insect serotonin receptor types from Manduca (the Ms5HTRs).
293 lution room-temperature structure of a human serotonin receptor using sub-10-micrometer microcrystals
294 on of 100 graphics models of the human 5-HT6 serotonin receptor was constructed based on the structur
295 BTs to known antagonists of the dopamine and serotonin receptors, we explored the roles of two of the
296 pamine, tyrosine hydroxylase, and the 5-HT5A serotonin receptor were increased in the cerebral cortex
297                         In brain parenchyma, serotonin receptors were expressed on oligodendrocytes a
298 RETATION: Our findings suggest activation of serotonin receptors with lorcaserin may provide the firs
299  alpha1 noradrenergic (alpha1 NE), and 5-HT2 serotonin receptors within the pre-Botzinger complex (pr
300 cules tested had relatively low affinity for serotonin receptors, yet a preliminary screen indicated

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top